The observation that CCR5Δ32 delays or prevents HIV-1 infection without affecting health encouraged the development of related anti-AIDS therapeutic strategies, from the disruption of the virus-CCR5 interaction to the inhibition of expression of functional CCR5 co-receptors (summarized in Tables 1 and 2). Here, CCR5 is linked to HIV-1 infection.